Spark Therapeutics Reports 2015 Financial Results and Business Highlights

Go back to Spark Therapeutics Reports 2015 Financial Results and Business Highlights

Spark Therapeutics (ONCE) Tops Q4 EPS by 49c

March 9, 2016 8:18 AM EST

Spark Therapeutics (NASDAQ: ONCE) reported Q4 EPS of ($0.24), $0.49 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Spark Therapeutics (ONCE) click here.

... More